Research Reports
Download Fact Sheet
Revere Research Reports are an indispensable source of valuable information and analysis on topics ranging from healthcare events, competitor overviews, product pipeline analysis, supplier analysis and thousands of merger and acquisition scenarios. All Revere reports are powered by the Revere Hierarchy™ and most include a rich array of other Revere content sources, such as Revere Relationships™ and Revere Products™.
Merger and Acquisition Scenario Report
See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships.
Sample:
Merger and Acquisition Scenario for AT&T Inc. (T) and Centennial Communications Corp. (CYCL) Revere - Oct 16, 2009 - HTML - View Report »
Drug/Medical Device Report
The most complete and accurate coverage of a company's FDA approved products and pipeline candidates.
Sample:
Drug/Medical Device for Amgen, Inc. (AMGN) Revere - Jan 27, 2007 - PDF - View Report »
FDA Approval Decisions Report
Comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs.
Sample:
FDA Approval Decisions Report for Nov, 2006 Revere - Nov 01, 2006 - PDF - View Report »
MedTech PMA Pipeline Monitor
Comprehensive and accurate event calendars for expected FDA approval dates for PMA filed medical devices.
Competitors by Product Report
Exact product by product comparables to each of a company's competitors which trade on a major US exchange.
Sample:
Competitors by Product for CBS Corporation (CBS) Revere - Oct 16, 2009 - HTML - View Report »
Company Profile Report
Highlights a company's products and services and key business relationships.
Sample:
Company Profile for Intel Corporation (INTC) Revere - Oct 16, 2009 - HTML - View Report »
New BioMedicine Event Report
Provides in-depth analysis relating to an upcoming event for a select pipeline drug and forecasts the expected event outcome.
Sample:
New BioMedicine Special Event Report for Avanir Pharmaceuticals, Inc. (AVNR) - Phase III STAR trial data of Zenvia for Pseudobulbar Affect/PBA New BioMedicine - Jul 31, 2009 - PDF - View Report »